INTERACTOR1 | INT1_HGNC_ID | INTERACTOR2 | INT2_HGNC_ID | INTERACTION_TYPE | CSC_METHOD | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | INTERACTION_METHOD | EXPRESSION_LEVEL | PUBMED_ID |
---|
NFATC2 | 7776 | ABCG2 | 74 | Protein-Gene Interaction | FACs for CSC marker | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP-qPCR | Up | 33707423
|
MIR582 | 32838 | BMP4 | 1071 | miRNA-mRNA Interaction | SFA and SP assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR582 mimic followed by qRT-PCR | Up | 26468775
|
MIR582 | 32838 | CCND1 | 1582 | miRNA-mRNA Interaction | SFA and SP assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR582 mimic followed by qRT-PCR | Up | 26468775
|
MIR582 | 32838 | CD44 | 1681 | miRNA-mRNA Interaction | SFA and SP assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR582 mimic followed by qRT-PCR | Up | 26468775
|
ELAVL1 | 3312 | CDK3 | 1772 | RNA-Protein Interaction | FACs followed by SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | RIP assay | Up | 29344850
|
MIR582 | 32838 | FGF18 | 3674 | miRNA-mRNA Interaction | SFA and SP assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR582 mimic followed by qRT-PCR | Up | 26468775
|
TBX21 | 11599 | IL4 | 6014 | Protein-Gene Interaction | SP assay and FACs for CSC marker | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP assay followed by PCR | Up | 29615105
|
POU5F1 | 9221 | LGALS3 | 6563 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | Stable forced expression of POU5F1 followed by qRT-PCR | Up | 26447186
|
POU5F1 | 9221 | MMP2 | 7166 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP assay followed by Luciferase Reporter assay | Up | 24386189
|
MIR582 | 32838 | MYC | 7553 | miRNA-mRNA Interaction | SFA and SP assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR582 mimic followed by qRT-PCR | Up | 26468775
|
NFATC2 | 7776 | NOTCH3 | 7883 | Protein-Gene Interaction | FACs for CSC marker | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP-qPCR | Up | 33707423
|
CTNNB1 | 2514 | PROM1 | 9454 | Protein-Gene Interaction | SFA and SP assay | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP assay followed by PCR | Up | 26075748
|
SMARCC2 | 11105 | SNAI2 | 11094 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP assay followed by qRT-PCR | Up | 27766570
|
MIR582 | 32838 | TWIST1 | 12428 | miRNA-mRNA Interaction | SFA and SP assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR582 mimic followed by qRT-PCR | Up | 26468775
|
UBE3C | 16803 | AHNAK | 347 | Protein-Protein Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 30503554
|
UBE3C | 16803 | AHNAK | 347 | Protein-Protein Interaction | SFA and ALDEFLUOR assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 30503554
|
CEBPB | 1834 | ALDH1A1 | 402 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP assay followed by qPCR | NA | 28420235
|
RNF168 | 26661 | RHOC | 669 | Protein-Protein Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 34873829
|
SOX2 | 11195 | CDK1 | 1722 | Protein-Protein Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 33721187
|
CTNNB1 | 2514 | CDH1 | 1748 | Protein-Protein Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 26075748
|
LGALS3 | 6563 | CTNNB1 | 2514 | Protein-Protein Interaction | SFA followed by FACs | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 25669973
|
EFEMP1 | 3218 | EGFR | 3236 | Protein-Protein Interaction | SFA and ALDEFLUOR assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 24013232
|
CDK3 | 1772 | ELAVL1 | 3312 | RNA-Protein Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | RIP assay followed by qRT-PCR | NA | 29344850
|
EFEMP1 | 3218 | IGF1R | 5465 | Protein-Protein Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 24013232
|
HSPB1 | 5246 | KLF4 | 6348 | Protein-Protein Interaction | SP assay and SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 28460458
|
HSPB1 | 5246 | MYC | 7553 | Protein-Protein Interaction | SP assay and SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 28460458
|
BACH1 | 935 | POU5F1 | 9221 | Protein-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP-qPCR | NA | 34949193
|
CD44 | 1681 | POU5F1 | 9221 | Protein-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP-qPCR | NA | 34949193
|
HSPB1 | 5246 | POU5F1 | 9221 | Protein-Protein Interaction | SP assay and SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 28460458
|
NDRG1 | 7679 | SKP2 | 10901 | Protein-Protein Interaction | SP assay and SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay | NA | 28456659
|
BACH1 | 935 | SOX2 | 11195 | Protein-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP-qPCR | NA | 34949193
|
CD44 | 1681 | SOX2 | 11195 | Protein-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP-qPCR | NA | 34949193
|
HSPB1 | 5246 | SOX2 | 11195 | Protein-Protein Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 28460458
|
SNAI2 | 11094 | SOX9 | 11204 | Protein-Protein Interaction | SFA and SP assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 26387547
|
CTNNB1 | 2514 | SPP1 | 11255 | Protein-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP assay followed by RT- PCR | NA | 29254164
|
SOX5 | 11201 | YAP1 | 16262 | Protein-Protein Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 29888108
|
BACH1 | 935 | NANOG | 20857 | Protein-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP-qPCR | NA | 34949193
|
CD44 | 1681 | NANOG | 20857 | Protein-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP-qPCR | NA | 34949193
|
HSPB1 | 5246 | NANOG | 20857 | Protein-Protein Interaction | SP assay and SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Co-IP assay followed by Western Blotting | NA | 28460458
|
FENDRR | 43894 | ABCB1 | 40 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Luciferase Reporter assay | Down | 30981768
|
CTNNB1 | 2514 | ABCG2 | 74 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of CTNNB1 followed by qRT-PCR | Down | 33980809
|
SOX2 | 11195 | ABCG2 | 74 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of SOX2 followed by qRT-PCR | Down | 23009336
|
ATG5 | 589 | ALDH1A1 | 402 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of ATG5 followed by qRT-PCR | Down | 33468994
|
CTNNB1 | 2514 | ALDH1A1 | 402 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of CTNNB1 followed by qRT-PCR | Down | 33980809
|
IL6 | 6018 | ALDH1A1 | 402 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of IL6 followed by qRT-PCR | Down | 27009878
|
ZEB1 | 11642 | ALDH1A1 | 402 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of ZEB1 followed by qRT-PCR | Down | 33468994
|
FOXD3 | 3804 | ALDH3A1 | 405 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP seq followed by qChIp | Down | 30703266
|
TSPYL5 | 29367 | ALDH1A3 | 409 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of TSPYL5 followed by qRT-PCR | Down | 34163000
|
MIR18A | 31548 | ATM | 795 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR18A mimic followed by Dual Luciferase Reporter assay | Down | 29860718
|
MIR582 | 32838 | AXIN1 | 903 | miRNA-mRNA Interaction | SFA and SP assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection of MIR582 mimics followed by RNA immunoprecipitation assay and qRT-PCR | Down | 26468775
|
NRP1 | 8004 | BMI1 | 1066 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of NRP1 followed by qRT-PCR | Down | 29138851
|
FOXD3 | 3804 | CBX3 | 1553 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP seq followed by qChIp | Down | 30703266
|
BACH1 | 935 | CD44 | 1681 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of BACH1 followed by qRT-PCR | Down | 34949193
|
TSPYL5 | 29367 | CD44 | 1681 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of TSPYL5 followed by qRT-PCR | Down | 34163000
|
MIR150 | 31537 | CTNNB1 | 2514 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Luciferase Reporter assay | Down | 31121479
|
PROM1 | 9454 | CXCR4 | 2561 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRAN mediated knockdown of PROM1 followed by qRT-PCR | Down | 28000861
|
MIR582 | 32838 | DKK3 | 2893 | miRNA-mRNA Interaction | SFA and SP assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection of MIR582 mimics followed by RNA immunoprecipitation assay and qRT-PCR | Down | 26468775
|
MIR129-1 | 31512 | DLK1 | 2907 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR129-1 mimics followed by qRT-PCR and Western Blotting | Down | 28619508
|
MIR708 | 33654 | DNMT3A | 2978 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR708 mimics followed by Luciferase Reporter assay and Western Blotting | Down | 28972040
|
MIR1290 | 35283 | FRK | 3955 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with miR1290 mimmics followed by Luciferase Reporter assay | Down | 25783528
|
MIR410 | 32065 | GSK3B | 4617 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection of MIR410 mimics followed by Luciferase Reporter assay | Down | 28076327
|
MIR18A | 31548 | HIF1A | 4910 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR18A mimic followed by Dual Luciferase Reporter assay | Down | 29860718
|
FOXD3 | 3804 | HMGB1 | 4983 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP seq followed by qChIp | Down | 30703266
|
MIR150 | 31537 | HMGA2 | 5009 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Luciferase Reporter assay | Down | 31121479
|
POU5F1 | 9221 | MMP2 | 7166 | Gene-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of POU5F1 followed by qRT-PCR | Down | 24386189
|
MIR128-1 | 31510 | MUC1 | 7508 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR128-1 followed by Luciferase Reporter assay | Down | 29299167
|
HDAC3 | 4854 | MYC | 7553 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP assay followed by PCR | Down | 30258097
|
ITGB1 | 6153 | MYC | 7553 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of ITGB1 followed by RT-PCR | Down | 30485693
|
SLC16A1 | 10922 | MYC | 7553 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of ZIC2 followed by qRT-PCR | Down | 32922547
|
SOX2 | 11195 | MYC | 7553 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of SOX2 followed by RT-PCR | Down | 22615765
|
TP53 | 11998 | MYC | 7553 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP assay followed by qRT-PCR | Down | 30503554
|
UBE3C | 16803 | MYC | 7553 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of UBE3C followed by qRT-PCR | Down | 30503554
|
ZNF322 | 23640 | MYC | 7553 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP assay followed by PCR | Down | 30258097
|
SOX2 | 11195 | NOTCH1 | 7881 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of SOX2 followed by RT-PCR | Down | 22615765
|
ATG5 | 589 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of ATG5 followed by qRT-PCR | Down | 33468994
|
BACH1 | 935 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of BACH1 followed by qRT-PCR | Down | 34949193
|
IL6 | 6018 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of IL6 followed by qRT-PCR | Down | 27009878
|
ITGB1 | 6153 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of ITGB1 followed by RT-PCR | Down | 30485693
|
LDHA | 6535 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of LDHA followed by qRT-PCR | Down | 34178639
|
NRP1 | 8004 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of NRP1 followed by qRT-PCR | Down | 29138851
|
TCF7 | 11639 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of lnc TCF 7 followed by qRT-PCR | Down | 27766570
|
ZEB1 | 11642 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of ZEB1 followed by qRT-PCR | Down | 33468994
|
UBE3C | 16803 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of UBE3C followed by qRT-PCR | Down | 30503554
|
MIR122 | 31501 | PRDX2 | 9353 | miRNA-mRNA Interaction | Enrichment by Gefitinib drug | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR122 mimic followed by Western Blotting and ICC staining | Down | 30341415
|
ATG5 | 589 | PROM1 | 9454 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of ATG5 followed by qRT-PCR | Down | 33468994
|
IL6 | 6018 | PROM1 | 9454 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of IL6 followed by qRT-PCR | Down | 27009878
|
ITGB1 | 6153 | PROM1 | 9454 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of ITGB1 followed by RT-PCR | Down | 30485693
|
SLC16A1 | 10922 | PROM1 | 9454 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | Lentiviral mediated knockdown of SLC16A1 followed by qRT-PCR | Down | 31891569
|
ZEB1 | 11642 | PROM1 | 9454 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of ZEB1 followed by qRT-PCR | Down | 33468994
|
MIR5100 | 43540 | RAB6A | 9786 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR5100 mimic followed by Luciferase Reporter assayand Western Blotting | Down | 29144562
|
MIR485 | 32067 | RXRA | 10477 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR485 mimic followed by Dual Luciferase Reporter assay | Down | 30058740
|
FOXD3 | 3804 | SET | 10760 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP seq followed by qChIp | Down | 30703266
|
MIR582 | 32838 | SFRP1 | 10776 | miRNA-mRNA Interaction | SFA and SP assay | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection of MIR582 mimics followed by RNA immunoprecipitation assay and qRT-PCR | Down | 26468775
|
BACH1 | 935 | SOX2 | 11195 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of BACH1 followed by qRT-PCR | Down | 34949193
|
IL6 | 6018 | SOX2 | 11195 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of IL6 followed by qRT-PCR | Down | 27009878
|
ITGB1 | 6153 | SOX2 | 11195 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of ITGB1 followed by RT-PCR | Down | 30485693
|
LDHA | 6535 | SOX2 | 11195 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of LDHA followed by qRT-PCR | Down | 34178639
|
TCF7 | 11639 | SOX2 | 11195 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of lnc TCF 7 followed by qRT-PCR | Down | 27766570
|
TP53 | 11998 | SOX2 | 11195 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP assay followed by qRT-PCR | Down | 30503554
|
TCF7 | 11639 | EpCAM | 11529 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of lnc TCF 7 followed by qRT-PCR | Down | 27766570
|
FOXD3 | 3804 | WDR5 | 12757 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP seq followed by qChIp | Down | 30703266
|
FOXD3 | 3804 | NSD2 | 12766 | Protein-Gene Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | ChIP seq followed by qChIp | Down | 30703266
|
SOX2 | 11195 | WNT1 | 12774 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of SOX2 followed by RT-PCR | Down | 22615765
|
MIR214 | 31591 | CTNNBIP1 | 16913 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Transfection with MIR214 mimmics followed by Luciferase Reporter assay and qRT-PCR | Down | 26299367
|
MIR150 | 31537 | GSKIP | 20343 | miRNA-mRNA Interaction | SFA | Non Small Cell Lung Cancer | Carcinoma | A549 | Luciferase Reporter assay | Down | 31121479
|
ATG5 | 589 | NANOG | 20857 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of ATG5 followed by qRT-PCR | Down | 33468994
|
BACH1 | 935 | NANOG | 20857 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of BACH1 followed by qRT-PCR | Down | 34949193
|
CTNNB1 | 2514 | NANOG | 20857 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of CTNNB1 followed by qRT-PCR | Down | 33980809
|
IL6 | 6018 | NANOG | 20857 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | SiRNA mediated knockdown of IL6 followed by qRT-PCR | Down | 27009878
|
ITGB1 | 6153 | NANOG | 20857 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of ITGB1 followed by RT-PCR | Down | 30485693
|
LDHA | 6535 | NANOG | 20857 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of LDHA followed by qRT-PCR | Down | 34178639
|
TCF7 | 11639 | NANOG | 20857 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of lnc TCF 7 followed by qRT-PCR | Down | 27766570
|
ZEB1 | 11642 | NANOG | 20857 | Gene-Gene Interaction | NA | Non Small Cell Lung Cancer | Carcinoma | A549 | ShRNA mediated knockdown of ZEB1 followed by qRT-PCR | Down | 33468994
|